Get the Stockscreener App
0.93
1.06%
-0.010
After Hours:
.93
Iridex Corp stock is traded at $0.93, with a volume of 27,124.
It is down -1.06% in the last 24 hours and down -13.89% over the past month.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
See More
Previous Close:
$0.94
Open:
$0.92
24h Volume:
27,124
Relative Volume:
0.33
Market Cap:
$15.99M
Revenue:
$48.43M
Net Income/Loss:
$-11.04M
P/E Ratio:
-1.3881
EPS:
-0.67
Net Cash Flow:
$-7.00M
1W Performance:
-5.10%
1M Performance:
-13.89%
6M Performance:
-8.82%
1Y Performance:
-45.93%
1-Day Range:
$0.9001
$0.9553
1-Week Range:
$0.9001
$0.99
52-Week Range:
$0.782
$1.95
Iridex Corp Stock (IRIX) Company Profile
Name
Iridex Corp
Sector
Industry
Phone
(650) 940-4700
Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
0.93 | 16.16M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-17 | Resumed | ROTH Capital | Buy |
| Dec-21-16 | Initiated | ROTH Capital | Buy |
| Jan-26-16 | Initiated | Singular Research | Buy |
| Jan-03-07 | Initiated | First Albany | Buy |
Iridex Corp Stock (IRIX) Latest News
Iridex CFO Dizon buys $5529 in company stock By Investing.com - Investing.com Nigeria
Iridex CFO Dizon buys $5529 in company stock - Investing.com
[Form 4] IRIDEX CORP Insider Trading Activity - Stock Titan
Iridex CFO Dizon buys $960 in company stock By Investing.com - Investing.com South Africa
Iridex CFO Dizon buys $960 in company stock - Investing.com
Will IRIDEX Corporation stock keep outperforming rivals2025 Key Highlights & Safe Entry Zone Tips - newser.com
Iridex CFO Dizon buys $2k in company stock By Investing.com - Investing.com Nigeria
Iridex CFO Dizon buys $2k in company stock - Investing.com
How IRIDEX Corporation stock reacts to global recession fears2025 Buyback Activity & Weekly Return Optimization Alerts - newser.com
Why IRIDEX Corporation stock is a must watch in 2025Weekly Market Outlook & Low Volatility Stock Recommendations - newser.com
Iridex CFO Dizon buys shares worth $2998 By Investing.com - Investing.com Nigeria
Iridex director Moore buys shares worth $48,331 By Investing.com - Investing.com South Africa
IRIDEX Corp Director William M Moore Acquires 50,000 Shares - TradingView
Iridex director Moore buys shares worth $48,331 - Investing.com
Dir Moore Buys 50,000 ($48.3K) Of IRIDEX Corp [IRIX] - TradingView
Iridex CFO Dizon buys shares worth $2998 - Investing.com
Iridex CFO Dizon buys $12996 in IRIX stock By Investing.com - Investing.com Canada
Iridex CFO Dizon buys $12996 in IRIX stock - investing.com
IRIDEX CFO Romeo R Dizon Acquires 14,769 Shares - TradingView
Will IRIDEX Corporation stock gain from strong economyTrade Entry Report & Step-by-Step Swing Trade Plans - newser.com
Market reaction to IRIDEX Corporation’s recent newsEarnings Miss & Expert Verified Movement Alerts - newser.com
Analyzing recovery setups for IRIDEX Corporation investors2025 Top Decliners & Safe Swing Trade Setups - newser.com
Will IRIDEX Corporation continue its uptrendWeekly Profit Recap & Weekly Watchlist of Top Performers - newser.com
IRIDEX Corporation (NASDAQ:IRIX) Q3 2025 Earnings Call Transcript - Insider Monkey
[10-Q] IRIDEX CORP Quarterly Earnings Report | IRIX SEC FilingForm 10-Q - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Iridex: Q3 Earnings Snapshot - Stamford Advocate
IRIDEX Corp (IRIX) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Cost Management By GuruFocus - Investing.com Canada
IRIDEX Corp (IRIX) Q3 2025 Earnings Call Highlights: Revenue Gro - GuruFocus
Earnings call transcript: IRIDEX Q3 2025 misses earnings forecasts, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: IRIDEX Q3 2025 misses earnings forecasts, stock dips - Investing.com
IRIDEX earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Iridex Corporation Reports Third Quarter 2025 Financial Results with 8% Year-over-Year Revenue Growth - Quiver Quantitative
Iridex (NASDAQ: IRIX) cuts operating expenses 12%; adjusted EBITDA loss narrows - Stock Titan
Earnings Scheduled For November 11, 2025 - Benzinga
Can IRIDEX Corporation stock reach $100 price targetQuarterly Market Summary & Risk Controlled Stock Pick Alerts - newser.com
Is IRIDEX Corporation stock dividend yield sustainable2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Why IRIDEX Corporation stock could rally in 2025Weekly Loss Report & Verified Momentum Stock Ideas - newser.com
IRIDEX (NASDAQ:IRIX) vs. Dynasil Corporation of America (OTCMKTS:DYSL) Financial Analysis - Defense World
Iridex Corp Stock (IRIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):